We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$622M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$597M
3
CMCSA icon
Comcast
CMCSA
+$461M
4
UNH icon
UnitedHealth
UNH
+$409M
5
MXIM
Maxim Integrated Products
MXIM
+$343M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEL icon
10226
CALL
Velocity Financial
VEL
$717M
$413K ﹤0.01%
+31,400
New +$400K
YCS icon
10227
PUT
ProShares UltraShort Yen
YCS
$30M
$413K ﹤0.01%
+21,200
New +$405K
ZYNE
10228
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$413K ﹤0.01%
97,300
-15,300
-14% -$68.3K
CLAA.WS
10229
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$413K ﹤0.01%
510,069
+70
+0% +$66
ACRS icon
10230
PUT
Aclaris Therapeutics
ACRS
$851M
$412K ﹤0.01%
22,900
+12,500
+120% +$200K
PLMR icon
10231
PUT
Palomar
PLMR
$3.37B
$412K ﹤0.01%
5,100
-200
-4% -$16.5K
REK icon
10232
ProShares Short Real Estate
REK
$11.7M
$412K ﹤0.01%
22,443
+1,100
+5% +$19.6K
SRET icon
10233
Global X SuperDividend REIT ETF
SRET
$230M
$412K ﹤0.01%
14,450
+2,294
+19% +$67.1K
TMC icon
10234
TMC The Metals Company
TMC
$1.77B
$412K ﹤0.01%
90,077
-654,438
-88% -$6.25M
TRONW
10235
DELISTED
Corner Growth Acquisition Corp. 2 Warrants
TRONW
$412K ﹤0.01%
+400,299
New +$396K
SJR
10236
CALL
DELISTED
Shaw Communications Inc.
SJR
$412K ﹤0.01%
14,200
+4,600
+48% +$133K
CBU icon
10237
CALL
Community Bank
CBU
$3.46B
$411K ﹤0.01%
6,000
-4,200
-41% -$301K
HMC icon
10238
PUT
Honda
HMC
$41B
$411K ﹤0.01%
13,400
+1,700
+15% +$53.5K
OPLN
10239
PUT
Openlane
OPLN
$4.33B
$411K ﹤0.01%
25,100
-3,500
-12% -$59K
PSMT icon
10240
CALL
Pricesmart
PSMT
$5.56B
$411K ﹤0.01%
5,300
-2,300
-30% -$195K
TILE icon
10241
Interface
TILE
$2.19B
$411K ﹤0.01%
27,117
– –
WLKP icon
10242
CALL
Westlake Chemical Partners
WLKP
$765M
$411K ﹤0.01%
16,900
-11,400
-40% -$298K
ECOM
10243
CALL
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$411K ﹤0.01%
16,300
+4,400
+37% +$108K
CATO icon
10244
CALL
Cato Corp
CATO
$67.9M
$410K ﹤0.01%
24,800
+5,700
+30% +$95.2K
LAB icon
10245
Standard BioTools
LAB
$280M
$410K ﹤0.01%
62,153
-34,379
-36% -$226K
NPCE icon
10246
Neuropace
NPCE
$507M
$410K ﹤0.01%
+25,822
New +$542K
BDSX icon
10247
Biodesix
BDSX
$253M
$409K ﹤0.01%
2,485
-221
-8% -$41.9K
CCC
10248
CALL
CCC Intelligent Solutions
CCC
$4.11B
$409K ﹤0.01%
38,900
+8,400
+28% +$86.8K
FDIS icon
10249
CALL
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.72B
$409K ﹤0.01%
5,100
-100
-2% -$8.2K
NPO icon
10250
CALL
Enpro
NPO
$7.27B
$409K ﹤0.01%
+4,700
New +$413K
408 409
410
411 412

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.